GlassScriptPhysician profile
Megan L Kessler
NPI 1891774436
$1,194.50
in general payments reported to CMS, 2019-2025
18 companies · $473 in 2025
The $473 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $12.36 · 2022: $245 · 2023: $186 · 2024: $145 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $803.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $803.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $254.75 | 2025 | Stripper, Origio Sequential Fert, Paragard T 380a |
| Gynesonics, INC. | $241.69 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Astellas Pharma US INC | $142.94 | 2023-2025 | Veozah |
| Ferring Pharmaceuticals INC. | $126.69 | 2023 | |
| Pfizer INC. | $81.59 | 2019-2025 | |
| Therapeuticsmd, INC. | $54.21 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $53.07 | 2019-2025 | Gardasil 9 |
| Sage Therapeutics, LLC | $46.49 | 2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $28.87 | 2022-2025 | |
| Avion Pharmaceuticals | $25.37 | 2019 | |
| Sumitomo Pharma America, INC. | $21.33 | 2024 | Myfembree |
| Roche Diagnostics Corporation | $21.22 | 2019 | |
| Millicent US INC | $18.30 | 2025 | Intrarosa |
| Ethicon US, LLC | $17.60 | 2025 | Vistaseal, Stratafix, Surgicel Nu-Knit |
| Amgen INC. | $16.40 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $15.42 | 2022 | |
| Amag Pharmaceuticals, INC. | $15.36 | 2019 | |
| Ascend Therapeutics US, LLC | $13.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Kessler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.